Company Description

PeproMene Bio is a clinical-stage biotech company committed to developing novel therapies to treat cancers and immune disorders. Our BAFFR CAR-T therapy program is based on a novel antibody targeting the B-cell Activating Factor Receptor (BAFF-R)